Refine by
Platelet Articles & Analysis
28 articles found
The CD47 protein on platelets binds with signal regulatory protein alpha (SIRPα) on macrophages which stops macrophages from clearing platelets through phagocytosis and extends the duration platelets circulate in blood. ...
While platelets make up just between 0.5% and 1% of the total blood cells, they're central to body hemostasis. Platelets will kick in the endogenous and exogenous coagulation mechanisms to coagulate blood vessels, convert fibrinogen to fibrin, and create clots with blood cells to close the wounding blood vessels and cause hemostasis. The platelet ...
To address this, researchers often use serum-free media supplemented with specific cytokines, such as EPO, nerve growth factor (NGF), platelet-derived growth factor (PDGF), and EGF, to support optimal cell growth and differentiation. ...
Background CellRight Technologies® has developed ACTIGEN™ Verified Inductive Bone Matrix, a dehydrated, verified inductive matrix that may be hydrated with saline, blood, Bone Marrow Aspirate (BMA), Platelet Rich Plasma (PRP), or other cellular components in accordance with a physician’s well-informed medical judgment. ...
Blood contains various cell types, including red blood cells, white blood cells, and platelets. For histone modification research, the focus is usually on white blood cells because they contain cell nuclei, and histones are found within the nucleus. ...
Dermal fibroblasts and leukocytes are the main sources of MMP, especially MMP-2. Platelets are an important source of MMP-1, MMP-2, MMP-3 and MMP-14. ...
PEG is biocompatible and exhibits low protein and platelet adsorption in vivo as well as low cellular adherence, which are features that have led to a wide range of applications in biomedical fields. ...
Caplacizumab targets von Willebrand factor (vWF), inhibits the interaction between vWF and platelets, and is indicated for acquired thrombotic thrombocytopenic purpura (aTTP) bacilli. ...
Similar events have been described for IAV; e.g., interaction of the virus with the platelet-derived growth factor receptor (PDGFRβ) during entry led to the activation of the Raf/MEK/ERK signaling pathway (Vrijens et al., 2019). ...
They’re caused by issues such as aberrant platelets, abnormal clotting proteins, or problematic blood vessels. Understanding how blood clots normally can help elucidate why these disorders are so serious. In a standard clotting process, platelets, a type of blood cell, act as first responders to an injury site. These platelets work in ...
L1CAM (L1 Cell Adhesion Molecule): L1CAM plays a role in neural development, axon guidance, and cell migration. PECAM-1 (Platelet Endothelial Cell Adhesion Molecule-1): PECAM-1 is expressed on the surface of platelets and endothelial cells and is involved in cell adhesion and signaling during immune responses. ...
For instance, the thrombopoietin receptor agonist (TPO-RAs) Avatrombopag Maleate, developed by Astellas Pharma, Inc. and approved by the US FDA in 2018, is currently the conventional drug for thrombocytopenia in European and American countries, which plays the most important regulatory role in megakaryocyte proliferation, differentiation, maturation, and mediating platelet ...
The remaining white blood cells and platelets are stored in a cryopreservation solution and frozen at temperatures below -80°C. ...
That includes not only packed red blood cells, but also platelets, plasma, and other components back to the patient during that same surgery. ...
Ceramide and Cardiovascular Diseases Elevated ceramide concentrations can lead to apoptosis of vascular endothelial cells and regulate platelet activation and coagulation, leading to thrombosis. It also regulates angiotensin, which can lead to atherosclerosis and a number of cardiovascular diseases such as hypertension. ...
Also, all the PAs showed significantly reduced platelet adhesion when compared with collagen I (control). These findings would facilitate the development of novel vascular grafts, heart valves, and cell based therapies for cardiovascular diseases. ...
Co-founder Ryan Bethencourt is one of the investors behind Sustainable Food Ventures Cultivated Meat Startups Landscape: Enabling Technologies Here’s the full list in alphabetical order: Agulos Biotech (US, 2017, cell culture media) — developing Simulated Platelet Lysate (porcine), a replacement for FBS Back of the Yards Algae Sciences (US, 2018, cell culture ...
Blood is made up of many different components which interact constantly with each other and the rest of our body: red blood cells bring the necessary oxygen to the cells of our body, white blood cells kill any pathogen they can find, platelets can prevent bleeding in case of injury, nutrients from our digestive system are transported by the blood flow, and many different kind of ...
Another top-selling covalent drug is clopidogrel, which needs to be activated by P450 oxidase in the liver to produce a sulphur-containing compound that then forms a disulfide bond with a cysteine residue in the P2Y12 receptor to inhibit platelet coagulation. The above-mentioned two drugs are now very widely used and were not originally designed to act in a covalent bonding form. ...
Inc. internal R&D funds and funds from Platelet and Thrombosis Research, LLC, Baltimore, MD, USA Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. ...